Compare CBUS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | NNOX |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 137.8M |
| IPO Year | 2017 | 2019 |
| Metric | CBUS | NNOX |
|---|---|---|
| Price | $1.43 | $1.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $9.00 | $5.00 |
| AVG Volume (30 Days) | 284.5K | ★ 1.2M |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $112.72 | $147.55 |
| Revenue Next Year | $83.18 | $81.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $1.59 |
| 52 Week High | $4.19 | $5.72 |
| Indicator | CBUS | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 46.26 | 52.04 |
| Support Level | $1.43 | $1.63 |
| Resistance Level | $1.50 | $3.09 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 68.89 | 88.75 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.